Evacetrapib

SI-6776

Evacetrapib, >98% (HPLC)

CAS No. : [1186486-62-3]

Synonyms : LY-2484595

IUPAC Name : (1S,4r)-4-(((S)-5-((3,5-Bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexane-1-carboxylic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Evacetrapib selectively inhibits CETP with nanomolar potency, blocking recombinant human CETP (IC₅₀= 5.5 nM) and plasma CETP activity (IC₅₀ = 36 nM). It is a valuable tool for studying CETP‑mediated HDL and LDL regulation.

References : Cao. G. et al.: J. Lipid Res., 52(12), 2169-76, 2011.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.